CancerConsultants Announces Recent Updates to the Pancreatic Cancer Information Center

As of April 21, 2008 CancerConsultants.com has completed our most recent updates to our Pancreatic Cancer Information Center, adding the latest findings in prevention, screening, treatment, and cancer management to our comprehensive, in-depth pancreatic cancer content.

As part of Cancer Consultants’ ongoing mission to provide interested individuals, cancer patients, and their families and caregivers with access to the most current information about the prevention, screening, treatment, and overall management of cancer, we regularly update our content with recent, ground-breaking findings in all aspects of cancer prevention and care. Our almost thirty unique Cancer Information Centers cover a broad range of cancer types and subtypes, each providing readers with up-to-date disease overviews as well as the latest information on screening, prevention, and treatment. Each information center also features links to late-breaking news, tips for patients, newsletter subscriptions, clinical trials information, online communities, and more.

Featured Pancreatic Cancer Information Center Update:

Updates to the Pancreatic Cancer Information Center discuss the importance of the chemotherapy drug Gemzar® (gemcitabine); the role of other systemic therapies such as Tarceva® (erlotinib), Platinol® (cisplatin) and Erbitux® (cetuximab); uncertainties about the role of radiation therapy; and novel treatment approaches such as anticancer vaccines and therapies that target the ras gene.

For more of the latest information on pancreatic cancer, visit the Pancreatic Cancer Information Center.

As of April 21, 2008 CancerConsultants.com has completed our most recent updates to our Pancreatic Cancer Information Center, adding the latest findings in prevention, screening, treatment, and cancer management to our comprehensive, in-depth pancreatic cancer content.

As part of Cancer Consultants’ ongoing mission to provide interested individuals, cancer patients, and their families and caregivers with access to the most current information about the prevention, screening, treatment, and overall management of cancer, we regularly update our content with recent, ground-breaking findings in all aspects of cancer prevention and care. Our almost thirty unique Cancer Information Centers cover a broad range of cancer types and subtypes, each providing readers with up-to-date disease overviews as well as the latest information on screening, prevention, and treatment. Each information center also features links to late-breaking news, tips for patients, newsletter subscriptions, clinical trials information, online communities, and more.

Featured Pancreatic Cancer Information Center Update:

Updates to the Pancreatic Cancer Information Center discuss the importance of the chemotherapy drug Gemzar® (gemcitabine); the role of other systemic therapies such as Tarceva® (erlotinib), Platinol® (cisplatin) and Erbitux® (cetuximab); uncertainties about the role of radiation therapy; and novel treatment approaches such as anticancer vaccines and therapies that target the ras gene.

For more of the latest information on pancreatic cancer, visit the Pancreatic Cancer Information Center.